Christophe Corpechot

16.0k citations

115 papers · 7.9k indexed · 3 hit papers · h-index 37

Hepatology top 0.1%
Epidemiology top 0.5%
Surgery top 1%
Neurology top 0.5%
Molecular Biology top 10%

Co-authors: Olivier Chazouillères Raoul Poupon Yves Chrétien Dominique Wendum Fabrice Carrat Gideon M. Hirschfield Pietro Invernizzi Christoph Schramm
Topics: Liver Diseases and Immunity (89 papers)Liver Disease Diagnosis and Treatment (75 papers)Pediatric Hepatobiliary Diseases and Treatments (37 papers)
Cited by: Hepatology Epidemiology Neurology
Journals: Nature The LancetSHILAP Revista de lepidopterología
Partner nations: France Italy United Kingdom

In The Last Decade

Christophe Corpechot

103 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia

1996 1.5k citations Christophe Corpechot et al. profile →
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

2017 886 citations Christophe Corpechot et al. Journal of Hepatology profile →
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients

1997 500 citations Christophe Corpechot et al. profile →

Peers

Countries citing papers authored by Christophe Corpechot

Since Specialization

Citations

This map shows the geographic impact of Christophe Corpechot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Corpechot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Corpechot more than expected).

Fields of papers citing papers by Christophe Corpechot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Corpechot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Corpechot. The network helps show where Christophe Corpechot may publish in the future.

Co-authorship network of co-authors of Christophe Corpechot

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Corpechot. A scholar is included among the top collaborators of Christophe Corpechot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Corpechot. Christophe Corpechot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PBC-HOPE: A Randomized Controlled Trial of Hypnosis and Psychoeducation in Women With Primary Biliary Cholangitis and Fatigue 2025 ·The American Journal of Gastroenterology ·Aurélie Untas,(unknown),Cécile Flahault,Christel Vioulac,Olivier Chazouillères,(unknown),Karima Ben Belkacem,Farid Gaouar,Nathalie Bernard,Alexandra Rousseau,Christophe Corpechot	0
2	Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study 2025 ·JHEP Reports ·Christophe Corpechot,(unknown),(unknown),(unknown),(unknown),(unknown),Karima Ben Belkacem,Farid Gaouar,(unknown),(unknown),Paola Squarzoni,(unknown),Sara Lemoinne,O. Chazouillères,(unknown)	0
3	Alkaline Phosphatase Changes With Seladelpar Across Subgroups Of Primary Biliary Cholangitis Patients In The Response Trial 2025 ·Digestive and Liver Disease ·(unknown),Kidist Yimam,(unknown),(unknown),Alan Bonder,Kessendri Reddy,Christophe Corpechot,Stephen F. Carroll,(unknown),Ke Yang,Daria B. Crittenden,Charles A. McWherter	0
4	Comparative effectiveness of peroxisome proliferator–activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis 2025 ·Hepatology ·(unknown),Nidah S. Khakoo,(unknown),John Reynolds,Christophe Corpechot,Alexandra Rousseau,Mohammed Murad,Shahnaz Sultan,Cynthia Levy	2
5	Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement 2024 ·Liver Transplantation ·Aldo J. Montaño‐Loza,Christophe Corpechot,Patrizia Burra,Christoph Schramm,Nazia Selzner,Vincenzo Ronca,Ye Htun Oo	4
6	Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis 2022 ·JHEP Reports ·Nora Cazzagon,S. El Mouhadi,(unknown),Carlos Ferreira,Sarah L. Finnegan,Sara Lemoinne,Christophe Corpechot,Olivier Chazouillères,Lionel Arrivé	15
7	Non-invasive diagnosis and follow-up of primary biliary cholangitis 2021 ·Clinics and Research in Hepatology and Gastroenterology ·Christophe Corpechot,Alexandra Heurgué,(unknown),Pascal Potier,(unknown),(unknown),Victor de Lédinghen,Nathalie Ganne‐Carrié,Christophe Bureau,Marc Bourlière	5
8	Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis 2021 ·Journal of Hepatology ·Atsushi Tanaka,Junko Hirohara,Toshiaki Nakano,Kosuke Matsumoto,Olivier Chazouillères,Hajime Takikawa,Bettina E. Hansen,Fabrice Carrat,Christophe Corpechot	71
9	Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis 2019 ·Clinics and Research in Hepatology and Gastroenterology ·Nora Cazzagon,Olivier Chazouillères,Christophe Corpechot,S. El Mouhadi,(unknown),B Desaint,Ulriikka Chaput,Sara Lemoinne,Lionel Arrivé	7
10	Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis 2019 ·Gut ·Sara Lemoinne,Astrid Kemgang,Karima Ben Belkacem,Marjolène Straube,Sarah Jégou,Christophe Corpechot,(unknown),Olivier Chazouillères,Chantal Housset,Harry Sokol	146
11	Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis 2016 ·Hepatology ·Géraldine Dahlqvist,Farid Gaouar,Fabrice Carrat,(unknown),Olivier Chazouillères,Raoul Poupon,Catherine Johanet,Christophe Corpechot	77
12	Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy 2015 ·Ultrasound in Medicine & Biology ·M. Sasso,(unknown),Astrid Kemgang,Farid Gaouar,Christophe Corpechot,Olivier Chazouillères,Céline Fournier,(unknown),(unknown),Y. Menu,Laurent Sandrin,Véronique Miette	108
13	Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases 2015 ·Clinics in Liver Disease ·Christophe Corpechot	13
14	Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis 2014 ·Gastroenterology ·Christophe Corpechot,Farid Gaouar,Ahmed El Naggar,Astrid Kemgang,Dominique Wendum,Raoul Poupon,Fabrice Carrat,Olivier Chazouillères	196
15	Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome 2011 ·Journal of Hepatology ·Christophe Corpechot,Olivier Chazouillères,Raoul Poupon	276
16	Hépatites auto-immunes : actualités diagnostiques et thérapeutiques 2010 ·La Revue de Médecine Interne ·Christophe Corpechot,Olivier Chazouillères	8
17	The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis 2005 ·Gastroenterology ·Christophe Corpechot,Fabrice Carrat,Abbas Bahr,Yves Chrétien,R Poupon,Raoul Poupon	261
18	Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA‐treated patients with primary biliary cirrhosis 2004 ·Liver International ·Christophe Corpechot,Armelle Poujol‐Robert,Dominique Wendum,(unknown),Yves Chrétien,Renée E. Poupon,Raoul Poupon	33
19	Hepatocyte Growth Factor and c-Met Inhibition by Hepatic Cell Hypoxia 2002 ·American Journal Of Pathology ·Christophe Corpechot,Véronique Barbu,Dominique Wendum,Nicolas Chignard,Chantal Housset,Raoul Poupon,Olivier Rosmorduc	65
20	The Effect of Ursodeoxycholic Acid Therapy on Liver Fibrosis Progression in Primary Biliary Cirrhosis 2000 ·Hepatology ·Christophe Corpechot,Fabrice Carrat,(unknown),Renée E. Poupon,Raoul Poupon,(unknown),(unknown)	222

About Christophe Corpechot

Christophe Corpechot is a scholar working on Hepatology, Epidemiology and Surgery, having authored 115 papers that have together received 7.9k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (89 papers), Liver Disease Diagnosis and Treatment (75 papers) and Pediatric Hepatobiliary Diseases and Treatments (37 papers). The work is most often cited by research in Hepatology (4.8k citations), Epidemiology (4.1k citations) and Neurology (1.5k citations). Christophe Corpechot has collaborated with scholars based in France, Italy and United Kingdom. Frequent co-authors include Olivier Chazouillères, Raoul Poupon, Raoul Poupon, Yves Chrétien, Dominique Wendum, Fabrice Carrat, Gideon M. Hirschfield, Pietro Invernizzi, Christoph Schramm and Chantal Housset. Their work appears in journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact